Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herbsino appears to be the commercial brand name used by Xi'an Saina Biological Technology Co., Ltd., a China-based manufacturer and supplier of botanical and plant-derived extracts. Publicly available company descriptions indicate it focuses on natural botanical extracts, including fruit extracts, herbal extracts, fatty acids, and ingredient products such as saw palmetto, bilberry, apple, pomegranate, guarana, acerola cherry, bitter melon, lotus leaf, and senna leaf extracts. The company seems to operate primarily as an ingredient supplier to food, nutraceutical, and wellness markets rather than as a drug developer with a clinical-stage therapeutic pipeline. Its business model is centered on extraction, production, quality control, and international supply of plant-based raw materials and related bioactive ingredients. Based on the available evidence, Herbsino is better characterized as a commercial natural-health ingredient manufacturer than as a biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herbsino.